Blood and Blood Forming Organs – Page 39 Pharmaceutical Schedule, September 2010 (224 pages, 1252 KB)

• Antianaemics Hypoplastic and Haemolytic; Megaloblastic
• Antifibrinolytics, Haemostatics and Local Sclerosants Antifibrinolytics, Haemostatics and Local Sclerosants; Vitamin K
• Antithrombotic Agents Antiplatelet Agents; Heparin and Antagonist Preparations; Oral Anticoagulants
• Fluids and Electrolytes Intravenous Administration; Oral Administration
• Lipid Modifying Agents Fibrates; Other Lipid Modifying Agents; Resins; HMG CoA Reductase Inhibitors (Statins); Selective Cholesterol Absorption Inhibitors
• Iron Overload Iron Overload